Oral Therapies
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11751 | Cabotegravir | An HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11751 | Cabotegravir | Solute carrier family 22 member 6 | transporter |
| DB11751 | Cabotegravir | Solute carrier family 22 member 8 | transporter |
| DB11751 | Cabotegravir | UDP-glucuronosyltransferase 1-1 | enzyme |
| DB11751 | Cabotegravir | UDP-glucuronosyltransferase 1-9 | enzyme |
| DB11751 | Cabotegravir | P-glycoprotein 1 | transporter |
| DB11751 | Cabotegravir | ATP-binding cassette sub-family G member 2 | transporter |
| DB11751 | Cabotegravir | Serum albumin | carrier |
| DB11751 | Cabotegravir | Integrase | target |
| Drug | Drug Name | Phase | Status | Count |
|---|